Skip to Content

Investors

About Fluidigm

Fluidigm (Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide. Together with them, we strive to increase the quality of life for all.

 

Why Invest?

Stock Chart

NASDAQ: FLDM

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Learn more